Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of micronucleotide hsa-mir939 in the diagnosis of hypertension

A micro nucleotide and high blood pressure technology, which is applied in the determination/inspection of microorganisms, biochemical equipment and methods, etc., can solve problems such as disability, family and national burden, and high mortality rate

Active Publication Date: 2016-08-24
YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases. Its major complications such as stroke, myocardial infarction, heart failure and chronic kidney disease not only cause disability and high mortality rate, but also seriously consume medical and social resources. heavy burden on the state

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of micronucleotide hsa-mir939 in the diagnosis of hypertension
  • Application of micronucleotide hsa-mir939 in the diagnosis of hypertension
  • Application of micronucleotide hsa-mir939 in the diagnosis of hypertension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In this embodiment, the present invention mainly discusses and clarifies the differentially expressed miRs in the process of prehypertension and hypertension through the research method of miR expression profile chip. This study revealed for the first time the expression changes of miRs related to prehypertension and hypertension, which not only helps to more comprehensively elucidate the molecular mechanism of hypertension, but also provides a series of new molecular markers for the evaluation of hypertension disease progression , and provided a series of new miR-based therapeutic targets, which laid a good foundation for the research and development of miR-based treatments for lowering blood pressure and protecting target organs in hypertension.

[0019] 1. Method

[0020] 1. Collection of samples for clinical research

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of microRNA (ribonucleic acid) has-miR939 in hypertension diagnosis. The application has the advantages as follows: plasma of hypertension patients in prehypertension and normal people is collected for research on whole-genome miR expression profile, research results show that a series of miRs are related to prehypertension and hypertension, and differentially expressed miRs help to explain the molecular mechanism for hypertension incidence; a molecular marker is provided for progress evaluation of prehypertension and hypertension; a brand new therapeutic target is provided for effective blood pressure control and treatment of prehypertension and hypertension; and meanwhile, an antagonist and a mimic containing a single miR or combining multiple miRs are adopted, and a brand new means is provided for treatment of prehypertension and hypertension.

Description

[0001] This application is a divisional application with an application date of November 26, 2013, application number 201310605650.4, and an invention titled "Application of Micronucleotides in the Diagnosis of Hypertension and Preparation of Antihypertensive Drugs". technical field [0002] The present invention relates to a new application of micro nucleotides, specifically, the application of micro nucleotides (microRNA) hsa-miR939 in the diagnosis of hypertension. Background technique [0003] Hypertension (hypertension) is a common chronic disease characterized by continuous increase in arterial blood pressure, which refers to arterial systolic blood pressure ≥ 140 mmHg and / or diastolic blood pressure ≥ 90 mmHg in a resting state. A systolic blood pressure of 120-139 mmHg and / or a diastolic blood pressure of 80-89 mmHg is called prehypertension or high normal. [0004] Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases. Its ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6883C12Q2600/136C12Q2600/158C12Q2600/178
Inventor 张腾陈瑜贾成林杨琴波王培伟李黎崔金刚杜宵烨宁冰冰刘丽
Owner YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com